Definitely sound like he is projecting RAC's clinical trial for RC220 which is in combination of SoC chemotherapy drug doxorubicin???? They did use RC110 which was approved to use in France 3 decades for AML and conducted the same in Ph1b/2 clinical trial 3 years ago, does that count as "runs on the board" lol.
IMU Price at posting:
4.3¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)